Case Report: Conversion therapy with chemotherapy, antiangiogenic therapy, and immunotherapy for locally advanced synchronous gastric hepatoid adenocarcinoma and poorly differentiated adenocarcinoma
Yin Shu, Feiyang Yan, Paerhati Shayimu, Weina Wang, Yajie Chen, Wenbin Zhang · 2026
Read Case Report: Conversion therapy with chemotherapy, antiangiogenic therapy, and immunotherapy for locally advanced synchronous gastric hepatoid adenocarcinoma and poorly differentiated adenocarcinoma by Yin Shu, Feiyang Yan, Paerhati Shayimu, Weina Wang, Yajie Chen, Wenbin Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13649471.txt.
Description
Yin Shu and five colleagues report a patient with two distinct stomach cancers at once, one of them a rare liver-like type tied to high levels of a blood marker. The disease at first looked beyond surgery. A team from many fields chose a four-part plan of two chemo drugs, an immune drug, and a drug that chokes tumour blood supply.
Scans showed the tumours shrank, and the blood marker fell back to normal. Surgeons then removed the whole stomach. Lab checks found no live cancer in either tumour bed or in 20 nearby lymph nodes, a full response. The authors warn that one case cannot set a standard, and follow-up was short.
Catalog record
| CREATOR | Yin Shu, Feiyang Yan, Paerhati Shayimu, Weina Wang, Yajie Chen, Wenbin Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 14 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |